# Study of Anti-telomerase T CD4 Immunity in Melanoma

> **NCT02838433** · NA · UNKNOWN · sponsor: **Centre Hospitalier Universitaire de Besancon** · enrollment: 200 (estimated)

## Conditions studied

- Melanoma

## Interventions

- **OTHER:** biological samples

## Key facts

- **NCT ID:** NCT02838433
- **Lead sponsor:** Centre Hospitalier Universitaire de Besancon
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02838433

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02838433, "Study of Anti-telomerase T CD4 Immunity in Melanoma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02838433. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*